Committed to helping you communicate

From pre-launce to product maturity, at Sunvally Communication we offer a whole range of specific communication services designed to meet and overcome the challenges brands faces throughout their complete lifecycle.

We develop farsighted, comprehensive and strategic communication and publication plans that sets out a direction for both the company and the product. This includes investigating, developing and producing integrated healthcare communications tools at different stages (from preclinical, phase I – IV, to post launch) of the product lifecycle.

Early Pharmacological and Pre Clinical

• Cultivate and establish contacts with all relevant opinion- and thought leaders

Launch Minus 48 Months or More: Phase I and II Trials

• Identify market needs
• Establish appropriate indication
• Keep up-to-date on clinical data requirements
• Establish product benefits
• Develop publication plan
• Develop PR approach
• Cultivate and establish contacts with opinion leaders
  

Launch Minus 48-24 Months: Phase I and IIIa/b Trials

• Establish markets & market segments;
• Identify key issues affecting the product;
• Search for likely trialists and members of an advisory panel(s)
• Set-up advisory panel(s) of expert/opinion leaders.
• Include input from advisory panel into:
• Clinical trials
• Communication and PR projects
• Project positioning
• Start-up a continuing program of publications
• Establish product positioning strategy
• Cultivate and establish contact with key specialists

Late Pre-launch, Minus 48-0 Months: Phase IIIa/b Trials

• Increase momentum of the ‘story’ behind the product
• Raise awareness of the condition to be treated and the problems it causes
• Identify any unfulfilled therapeutic needs
• Increase corporate identity/image of the corporation as a major partner in healthcare
• Careful planning of clear, consistent, persuasive and credible message
• Cultivate and establish contacts with specialists and advocacy groups

Launch

• Include last minute alterations in indications
• Increase communications activities for internal customers and prescribers
• Create awareness of new product availability
• Endorse product benefits
• Formulate a consistent and unified response to sensitive or damaging issues
• Cultivate and establish contacts with primary care physicians and nurses

Late Pre-launch and Launch - Major issues to consider

• Timing is very delicate when a company is launching a new product
• Gaining a honest opinion of leading clinicians can be particularly difficult if the company has no history in the specific specified therapeutic area, and……
• ....is reluctant to let the outside world know of its plans..

Launch, Plus 12 - 24 Months

• Increase and maintain interest of the loyalty chain of influence from opinion leaders and patient groups
• Establish a program to counter competition from emerging products
• Over time - and when required - establish a strategy to reposition the product
• Establish new markets
• Support product by launch of line extensions

Launch, Plus 12 - 24 Months - Major Issues to Consider

• Ensure that prescribers are fully aware of the likely benefits of the new therapeutic approach without directly promoting it
• Educate colleagues so that the can ‘hit the ground running’ when the product is available
• Be credible and establish an ethical approach